BETAThis is a new independent transparency project, not an official government website. The data is sourced from public registers and may contain errors, so always verify against the official source. If you find a problem, please report it here.
The Health and Social Care Apps DPS Dynamic Purchasing System was published under the Public Contracts Regulations 2015 (PCR 2015) as amended and will continue to be operated in accordance with the terms of that regime. Under current transitional guidance, DPS agreements established before the transition to the Procurement Act 2023 must come to an end by 23rd February 2029 at the latest. This applies regardless of any original DPS duration or end date, and allows the DPS to remain active and compliant, ensuring continuity and stability of the route to market for Contracting Authorities and Suppliers alike.<br/>Accordingly, the DPS is being extended and will expire on 23rd February 2029, subject to annual review, where NHS LPP reserve the right to extend, shorten or terminate, in part or whole, any categories or the entire DPS at any time.
No supplier information available.
This procurement was divided into 1 lots, each awarded separately.
| Lot | Value | Status |
|---|---|---|
| Lot 1 720 days (≈2 yrs) | £15,000,000 | active |
Changes the buyer published to this notice after it first appeared.
This is an extension of the DPS with multiple supplier awards. For the list of awarded suppliers please click on the link https://healthappsdps.orcha.co.uk/
Original CONTRACT NOTICE (04/10/2019) 2019/s 192-45638 https://ted.europa.eu/udl?uri=TED:NOTICE:465638-2019:TEXT:EN:HTML
Supplement notice (25/11/2019) 2019/s 227-557047 https://ted.europa.eu/udl?uri=TED:NOTICE:557047-2019:TEXT:EN:HTML
Notice (28/02/2020) 2020/s 042-100524 https://ted.europa.eu/udl?uri=TED:NOTICE:100524-2020:TEXT:EN:HTML
Notice (27/03/2020) 2020/s 062-149867 https://ted.europa.eu/udl?uri=TED:NOTICE:149867-2020:TEXT:EN:HTML
Notice (02/06/2020) 2020/s 105-255385 https://ted.europa.eu/udl?uri=TED:NOTICE:255385-2020:TEXT:EN:HTML
Notice (15/11/2021) 2021/s 221-584062 https://ted.europa.eu/udl?uri=TED:NOTICE:584062-2021:TEXT:EN:HTML
NHS London Procurement Partnership will add an additional category to the existing Health Apps DPS;Category 26 – NICE Accredited Apps An evidence-based therapeutic intervention delivered through software to prevent, manage, or treat a medical disorder or disease. They are typically accessed via a smartphone app or online and engage the patient without the involvement of a clinician.The evidence-based therapeutic intervention must be registered as a medical device and must be regulated by the MHRA for use in the UK. The evidence-based therapeutic intervention must be compliant with the Digital Technology Assessment Criteria (DTAC).Sub-Category 26.1 – Digital cognitive behavioural therapy for adults with insomniaAn evidence-based therapeutic intervention delivered through software to prevent, manage, or treat insomnia and insomnia symptoms. This intervention will be accessed via a smartphone app or online and engage the patient without the involvement of a clinician. The evidence-based therapeutic intervention must be registered as a medical device and must be regulated by the MHRA for use in the UK. The evidence-based therapeutic intervention must have proprietary Randomised Controlled Trial evidence that demonstrates safety and efficacy.The evidence-based therapeutic intervention must be compliant with the Digital Technology Assessment Criteria (DTAC).
NHS London Procurement Partnership will add an additional category to the existing Health Apps DPS;Category 26 – NICE Accredited Apps An evidence-based therapeutic intervention delivered through software to prevent, manage, or treat a medical disorder or disease. They are typically accessed via a smartphone app or online and engage the patient without the involvement of a clinician.The evidence-based therapeutic intervention must be registered as a medical device and must be regulated by the MHRA for use in the UK. The evidence-based therapeutic intervention must be compliant with the Digital Technology Assessment Criteria (DTAC).Sub-Category 26.1 – Digital cognitive behavioural therapy for adults with insomniaDigital cognitive behavioural therapy for adults with insomnia. An evidence-based therapeutic intervention delivered through software to prevent, manage, or treat insomnia and insomnia symptoms. This intervention will be accessed via a smartphone app or online and engage the patient without the need for prescription or referral. The evidence-based therapeutic intervention and its use in providing care and treatment to users should meet all relevant regulatory requirements. The evidence-based therapeutic intervention must either possess existing proprietary Randomised Controlled Trial (RCT) or Real World (RWE) evidence demonstrating safety and efficacy or have plans to generate such evidence1. The evidence-based therapeutic intervention must be compliant with the Digital Technology Assessment Criteria (DTAC).NICE Early Evaluation Assessment (EVA) products only
Published by the buyer on this notice. Check the original notice — details change and are not updated here.